Basic Sciences: Immunology

(Click here to return to the Media and Education Overview page.
If you find a broken link please inform us here.)


 Monoclonal Antibodies: Stanford Academia-Industry Collaboration (Video 51 mns)

August 22, 2007 presentation by Ron Levy for the Stanford School of Medicine Medcast lecture series. ??Ron Levy, MD, professor of Medicine at Stanford, recounts his experiences moving his discovery from the lab to the clinical setting and discusses the future of this cancer treatment. Wendy Harpham, a participant in the early clinical trials of Rituxan, the first FDA-approved monoclonal antibody for cancer treatment that Levy developed, provides a patient's perspective.

Click here to watch this video on YouTube